303 related articles for article (PubMed ID: 28057699)
1. Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.
Anderberg RH; Richard JE; Eerola K; López-Ferreras L; Banke E; Hansson C; Nissbrandt H; Berqquist F; Gribble FM; Reimann F; Wernstedt Asterholm I; Lamy CM; Skibicka KP
Diabetes; 2017 Apr; 66(4):1062-1073. PubMed ID: 28057699
[TBL] [Abstract][Full Text] [Related]
2. GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.
Anderberg RH; Richard JE; Hansson C; Nissbrandt H; Bergquist F; Skibicka KP
Psychoneuroendocrinology; 2016 Mar; 65():54-66. PubMed ID: 26724568
[TBL] [Abstract][Full Text] [Related]
3. Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation.
Leon RM; Borner T; Reiner DJ; Stein LM; Lhamo R; De Jonghe BC; Hayes MR
Neuropsychopharmacology; 2019 Sep; 44(10):1742-1751. PubMed ID: 30959513
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice.
Nonogaki K; Kaji T
J Diabetes Res; 2018; 2018():6482958. PubMed ID: 29484303
[TBL] [Abstract][Full Text] [Related]
5. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
6. Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.
Sisley S; Smith K; Sandoval DA; Seeley RJ
Peptides; 2014 Aug; 58():1-6. PubMed ID: 24879927
[TBL] [Abstract][Full Text] [Related]
7. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
8. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
9. The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.
Burmeister MA; Ayala JE; Smouse H; Landivar-Rocha A; Brown JD; Drucker DJ; Stoffers DA; Sandoval DA; Seeley RJ; Ayala JE
Diabetes; 2017 Feb; 66(2):372-384. PubMed ID: 27908915
[TBL] [Abstract][Full Text] [Related]
10. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Dorsal Tegmental Nucleus Regulates Energy Balance.
Reiner DJ; Leon RM; McGrath LE; Koch-Laskowski K; Hahn JD; Kanoski SE; Mietlicki-Baase EG; Hayes MR
Neuropsychopharmacology; 2018 Feb; 43(3):627-637. PubMed ID: 28920591
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
McKay NJ; Kanoski SE; Hayes MR; Daniels D
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPG neurons following acute stressors differentially involves hindbrain serotonin in male rats.
Leon RM; Borner T; Stein LM; Urrutia NA; De Jonghe BC; Schmidt HD; Hayes MR
Neuropharmacology; 2021 Apr; 187():108477. PubMed ID: 33581143
[TBL] [Abstract][Full Text] [Related]
16. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Vilsbøll T; Christensen M; Junker AE; Knop FK; Gluud LL
BMJ; 2012 Jan; 344():d7771. PubMed ID: 22236411
[TBL] [Abstract][Full Text] [Related]
17. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
Zhao S; Kanoski SE; Yan J; Grill HJ; Hayes MR
Int J Obes (Lond); 2012 Dec; 36(12):1522-8. PubMed ID: 22249232
[TBL] [Abstract][Full Text] [Related]
18. Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus.
Owji AA; Khoshdel Z; Sanea F; Panjehshahin MR; Shojaee Fard M; Smith DM; Coppock HA; Ghatei MA; Bloom SR
Brain Res; 2002 Mar; 929(1):70-5. PubMed ID: 11852032
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.
Reiner DJ; Mietlicki-Baase EG; McGrath LE; Zimmer DJ; Bence KK; Sousa GL; Konanur VR; Krawczyk J; Burk DH; Kanoski SE; Hermann GE; Rogers RC; Hayes MR
J Neurosci; 2016 Mar; 36(12):3531-40. PubMed ID: 27013681
[TBL] [Abstract][Full Text] [Related]
20. Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation.
Costa A; Ai M; Nunn N; Culotta I; Hunter J; Boudjadja MB; Valencia-Torres L; Aviello G; Hodson DJ; Snider BM; Coskun T; Emmerson PJ; Luckman SM; D'Agostino G
Mol Metab; 2022 Jan; 55():101407. PubMed ID: 34844019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
